July 11, 2014 7:50 AM ET


Company Overview of Progen Pharmaceuticals, Inc.

Key Executives for Progen Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Edward F. Schnipper M.D.26 RelationshipsChief Executive Officer, President and Director65
Thomas D. Kiley Esq.30 RelationshipsCo-Founder and Director71
Paul A. Wender Ph.D.37 RelationshipsCo-Founder, Chief Scientific Advisor and Director--
Richard G. Taylor CPANo RelationshipsVice President of Administration and Finance60
Laurence J. Marton M.D.77 RelationshipsChief Scientific Officer--

Progen Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Edward F. Schnipper M.D. 26 RelationshipsBIND Therapeutics, Inc.65
Thomas D. Kiley Esq. 30 RelationshipsProgen Pharmaceuticals, Inc.71
Paul A. Wender Ph.D. 37 RelationshipsProgen Pharmaceuticals, Inc.--
Michael G. Raab 31 RelationshipsArdelyx, Inc.49
Anthony E. Pegg Ph.D. 8 RelationshipsUniversity of Cambridge--
View All Board Members

Progen Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Progen Pharmaceuticals, Inc. CEO Compensation
Industry Average


Harbinger Group Inc. Announces New Directors
July 08, 2014 9:12 PM ET
Rubberex Corp. M Bhd Appoints Yee Choy Lean as Joint Secretary, Effective July 01, 2014
July 01, 2014 8:50 AM ET
SCA Names Charity Hughes as Vice Pesident of Human Resources, North America
June 26, 2014 12:00 AM ET
SCA Americas Names Dumitrache Martinez as Vice President, Finance
June 26, 2014 12:00 AM ET
The Procter & Gamble Company Elects Werner Geissler as Vice Chairman and Advisor to the Chairman and Chief Executive Officer, Effective July 1, 2014
June 25, 2014 2:03 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Progen Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.